This inventor holds 1 USPTO granted patent. Top assignee: Jubilant Organosys Limited. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Jwalant A Shastri: Innovator in Pharmaceutical Chemistry
Introduction
Jwalant A Shastri is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug synthesis. His work is characterized by a focus on producing pure and effective pharmaceutical compounds.
Latest Patents
Jwalant A Shastri holds a patent for a process titled "Process for producing pure form of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine." This innovative process involves the reaction of 2-(2-aminoanilino)-5-methylthiophene-3-carbonitrile with N-methyl piperazine, along with N-methylpiperazine acid salt, to yield the desired compound. Additionally, he has disclosed a method for obtaining Polymorphic Form I of the compound by crystallizing the crude product in a mixture of solvents. Jwalant A Shastri has 1 patent to his name.
Career Highlights
Jwalant A Shastri is currently employed at Jubilant Organosys Limited, a prominent player in the pharmaceutical industry. His role involves research and development, where he applies his expertise to enhance drug formulations and processes. His contributions have been instrumental in advancing the company's innovative capabilities.
Collaborations
Throughout his career, Jwalant has collaborated with talented professionals, including Akshat Bhatnagar and Rajesh Kumar Thaper. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical chemistry.
Conclusion
Jwalant A Shastri exemplifies the spirit of innovation in the pharmaceutical industry. His dedication to developing efficient processes for drug synthesis has made a significant impact on the field. His work continues to inspire future advancements in pharmaceutical research and development.